December 11 ICOC/ARS Meeting

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
APPLICATION REVIEW SUBCOMMITTEE AND
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH, TREATMENTS, AND CURES INITIATIVE OF 2020

Date: December 11, 2025
Time: 9:00 am to 4:00 pm*
Main Location: 601 Gateway Blvd., Suite 400
South San Francisco, CA 94080

 Members of the public may attend this meeting in person at the address printed above or remotely via the options listed below.

 

Teleconference Locations

4610 X St. Room 3101E, Sacramento, CA 95817 455 Capitol Mall Ste 315, Sacramento, CA 95814
327 McCartney Ct., Lincoln, CA 95648 44 Dorothy Way, Novato, CA 94945
500 Parnassus Avenue, San Francisco, CA 94143 600 16th St, S572D, San Francisco, CA 94158
3215 Porter Dr. Palo Alto, CA 94304 21211 Rainbow Drive, Cupertino CA 95014
291 Campus Drive, 3rd Floor, LKSC Building, Stanford, CA 94305 123 E. San Carlos St, Suite 413, San Jose, CA 95112
4005 N. Fresno St, Suite 104, Fresno, CA 93705 155 N Fresno St., Suite 319, Fresno, CA 93701
6220 Playa Vista Place, Avila Beach, CA 93424 4214 Elenda St, Culver City, CA 90230
4650 Sunset Blvd, MS#1, Los Angeles, CA 90027 8700 Beverly Blvd 2015 Los Angeles, CA 90048
12-231 Center for Health Sciences, David Geffen School of Medicine, UCLA 9301 Wilshire Blvd. Ste. 507, Beverly Hills, CA 90210
650 Charles E. Young Drive South, Room A2-237 CHS, Los Angeles, CA 90095 1500 E. Duarte Rd., Duarte, CA 91010-3000
1400 Biological Sciences III, Irvine, CA 92697 900 University Ave. Room 202E, Riverside, CA

92521
5500 Campanile Drive, San Diego, CA 92182-4162 9500 Gilman Dr. La Jolla, CA 92093

 

Public Comment Instructions

Members of the public attending the meeting at a teleconference location will be provided the opportunity for public comment at each location with the same limitations as those imposed on any other member of the public.

Written comment may be sent to the following email address: cmandac@cirm.ca.gov. Please note that letters received less than 48 hours before the meeting may not be distributed until after the meeting.

Members of the public who are listening to the meeting via teleconference and wish to make oral comment will have the opportunity to do so by doing the following: 

  • Once we have called for public comment, members of the public are to press *9 if joining by phone or raise a Zoom hand, which will place you in a queue to make your comment.
  • Once we call your name you may have up to 3 minutes (specific time dependent on the number of members of the public wishing to speak) to make your public comment; please remember to be respectful of the time limit.


YouTube:
https://www.youtube.com/cirmtv

Dial-In information:
Dial in number: (669) 900-6833
Meeting ID: 882 4171 4887
Passcode: 251211

 

Open Session

  1. Call to Order
  2. Roll Call
  3. Chair’s Report
  4. Vice-Chair’s Report
  5. President’s Report

Consent Calendar

  1. Consideration of Minutes from the September 25, 2025, ICOC/ARS Meeting and October 30, 2025, ARS Meeting
  2. Consideration of Appointments to the Grants Working Group

Open Session

  1. Consideration of Applications Submitted in Response to a Preclinical Development Program Announcements (PDEV)
  2. Consideration of Applications Submitted in Response to a Clinical Program Announcements (CLIN2)
  3. Consideration of the EDUC8 Concept Plan
  4. Consideration of an Amendment to the EDUC3 (SPARK) Concept Plan
  5. Consideration of the Award Management Policy
  6. Consideration of the Recommendation from Governance Subcommittee Regarding the CIRM Employee Conflict of Interest Policy
  7. Consideration of the Accessibility and Affordability Strategy
  8. Update on the Patient Support Program
  9. Discussion Regarding the CIRM Communications Strategy

Closed Session

  1. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to Preclinical Development and Clinical program announcements (Health & Safety Code 125290.30(f) (3) (B) and (C)). 

Open Session

  1. General Comments on the ARS Process
  2. Public Comment
  3. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens’ Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Claudette Mandac at the California Institute for Regenerative Medicine at 510-340-9101 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens’ Oversight Committee meeting may be referred to Claudette Mandac at the California Institute for Regenerative Medicine at cmandac@cirm.ca.gov.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov/.

The Committee may take action on any item listed on this agenda.

*The duration of the meeting is an estimate, only. The meeting may continue beyond this estimated time in order to address the items on this agenda.